Bhurgri Yasmin, Muzaffar Suhail, Ahmed Rashida, Ahmed Nafees, Bhurgri Hadi, Usman Ahmed, Faridi Naveen, Malik Jawaid, Kazi Liaquat Ali G, Bashir Imtiaz, Kayani Naila, Bhurgri Asif, Pervez Shahid, Hasan Sheema H, Soomro Akber Haider
Karachi Cancer Registry, Department of Pathology, Aga Khan University Hospital, Sindh Medical College, Stadium Road, Karachi 74800, Pakistan.
Asian Pac J Cancer Prev. 2004 Apr-Jun;5(2):159-63.
The objective was to assess epidemiologic aspects of retinoblastoma development in Karachi, Pakistan. Incident cases, diagnosed clinically or microscopically and registered at Karachi Cancer Registry (KCR) during 1(st)January 1998 to 31(st) December 2002 were reabstracted, rechecked and reanalyzed for this purpose. One hundred and one cases of retinoblastoma were reported to KCR over the 5 years (1998-2002). Fifty-seven were residents of Karachi, 34 (59.6%) males and 23 (40.4%) females. The gender ratio (M:F) was 1.5. The mean age at diagnosis was 3.96 years (95% CI 2.92; 4.99) and 3.85 years (95% CI 2.72; 4.98) in males and females respectively. The annual crude incidence of retinoblastomas in Karachi was 4.0/100,000 and 2.4/100,000 in children under the age of 5 and 10 years respectively, the corresponding age standardized rates being 5.3/100,000 and 4.8/100,000. The age groups at risk of developing retinoblastoma, associated morbidity and possibility of almost 100% 5-year survival with available treatments, calls for ophthalmologic screening of all infants below 1 year, and high-risk children until the age of 7 years. In order to detect retinoblastoma, as early as possible, health education for parents and health providers, and improved training of ophthalmologists is essential. Genetic testing for siblings and children of retinoblastoma cases and identification of high-risk children would be helpful, but lacks financial feasibility in developing countries at present. Future health care planning should focus on capacity building for neonatal ophthalmologic screening, handling of parents'and children'emotional reactions and opportunities for education, occupational training and cosmetic rehabilitation for surviving retinoblastoma patients.
目的是评估巴基斯坦卡拉奇视网膜母细胞瘤发病的流行病学特征。为此,对1998年1月1日至2002年12月31日期间在卡拉奇癌症登记处(KCR)临床诊断或经显微镜诊断并登记的新发病例进行了重新提取、复查和重新分析。在这5年(1998 - 2002年)期间,KCR共报告了101例视网膜母细胞瘤病例。其中57例是卡拉奇居民,男性34例(59.6%),女性23例(40.4%)。性别比(男:女)为1.5。男性和女性的诊断平均年龄分别为3.96岁(95%可信区间2.92;4.99)和3.85岁(95%可信区间2.72;4.98)。卡拉奇视网膜母细胞瘤的年粗发病率在5岁以下儿童中为4.0/10万,在10岁以下儿童中为2.4/10万,相应的年龄标准化发病率分别为5.3/10万和4.8/10万。鉴于存在患视网膜母细胞瘤风险的年龄组、相关发病率以及现有治疗手段几乎能实现100%的5年生存率,有必要对所有1岁以下婴儿以及7岁以下高危儿童进行眼科筛查。为了尽早发现视网膜母细胞瘤,对家长和医疗服务提供者进行健康教育以及加强眼科医生培训至关重要。对视网膜母细胞瘤病例的兄弟姐妹和子女进行基因检测并识别高危儿童会有帮助,但目前在发展中国家缺乏经济可行性。未来的医疗保健规划应侧重于新生儿眼科筛查能力建设、应对家长和儿童的情绪反应以及为幸存的视网膜母细胞瘤患者提供教育、职业培训和美容康复机会。